EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of SARS-CoV-2 on Viral Respiratory Infections in Patients with Hematological Malignancies

Antonio Giordano, Martina Quattrone, Marcello Viscovo, Barbara Fiori, Rosaria Santangelo, Maurizio Sanguinetti iD, Livio Pagano iD

Viruses · 2024

DOI: 10.3390/v16101520 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Antonio Giordano und 6 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento Scienze di Laboratorio ed Ematologiche, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 8 I-00168 Roma, Italy. Hauptthemen laut MEDLINE: COVID-19, Hematologic Neoplasms, Respiratory Tract Infections, SARS-CoV-2. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with hematological malignancies (HMs) are at high risk of respiratory viral infections due to the intrinsic deterioration of the immune system and chemotherapy treatments. In the recent past, SARS-CoV-2 respiratory viral infection has been responsible for most infectious complications in HMs. We analyzed 2950 samples from 505 patients admitted to the Hematology department from 2019 to 2023. The aim of this study was to determine the epidemiological trend of respiratory viruses in the SARS-CoV-2 era, the characteristics of the patients involved and their outcomes. In our analysis, we found a reduction in non-SARS-CoV-2 respiratory viral (NSRV) positivity during the pandemic period, although these data did not show statistical significance. Most of the HMs involved were Multiple Myeloma and Acute Myeloid Leukemia. Overall mortality rate was very low and characterized by the progression of the HMs as well as the worsening of respiratory failure. In conclusion, a reduction in non-COVID viral infections was highlighted, probably also thanks to the increase in prevention measures and environmental modifications of the viral background.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Hematologic NeoplasmsRespiratory Tract InfectionsSARS-CoV-2HumansMaleMiddle AgedFemaleAgedAdultAged, 80 and overMultiple Myeloma

Stichwörter der Autor:innen

COVID-19respiratory infectionsvirus

Autor:innen und Institutionen

  • Dipartimento Scienze di Laboratorio ed Ematologiche, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 8 I-00168 Roma, Italy.
  • Hematology Department, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Largo A. Gemelli, 8 I-00168 Rome, Italy.
  • Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, 8 I-00168 Roma, Italy.
  • Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Università Cattolica del Sacro Cuore, 8 I-00168 Roma, Italy.

ORCID-Profile: Maurizio Sanguinetti, Livio Pagano

Zitieren

APA

Giordano, A., Quattrone, M., Viscovo, M., Fiori, B., Santangelo, R., Sanguinetti, M., & Pagano, L. (2024). Impact of SARS-CoV-2 on Viral Respiratory Infections in Patients with Hematological Malignancies. Viruses. https://doi.org/10.3390/v16101520

Vancouver

Giordano A, Quattrone M, Viscovo M, Fiori B, Santangelo R, Sanguinetti M, et al. Impact of SARS-CoV-2 on Viral Respiratory Infections in Patients with Hematological Malignancies. Viruses. 2024. doi:10.3390/v16101520

BibTeX
@article{Giordano2024,
  author = {Giordano, Antonio and Quattrone, Martina and Viscovo, Marcello and Fiori, Barbara and Santangelo, Rosaria and Sanguinetti, Maurizio and Pagano, Livio},
  title = {Impact of SARS-CoV-2 on Viral Respiratory Infections in Patients with Hematological Malignancies},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16101520}
}
Kostenlos starten →